Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 98, Issue 2, 1998, Pages 102-109

  Kraus, J ^a   Oschmann, P ^a,c   Engelhardt, B ^b   Schiel, C ^a   Hornig, C ^a   Bauer, R ^a   Kern, A ^a   Traupe, H ^a   Dorndorf, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Central nervous system; Cerebrospinal fluid; Disease activity; ICAM 1; Multiple sclerosis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; DEMYELINATION; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE; TIME FACTORS;

EID: 0031825481     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MARTIN R, MCFARLAND HF, MCFARLIN DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992: 10: 153-87.
2. HAFLER DA, WEINER HL. MS: a CNS and systemic autoimmune disease. Immunol Today 1989: 10: 104-7.
3. RAINE CS. Multiple selerosis: a pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol 1991: 17: 265-74.
4. YEDNOCK TA, CANNON C, FRITZ LC, SANCHEZ, MADRID F, STEINMAN L, KARIN N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992: 356: 63-6.
5. STEFFEN BJ, BUTCHER EC, ENGELHARDT B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system of the SJL/J mouse. Am J Pathol 1994: 145: 189-201.
6. MARLIN SD, STAUNTON DE, SPRINGER TA, STRATOWA C, SOMMERGRUBER W, MERLUZZI VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990: 344: 70-2.
7. RIECKMANN P, NÜNKE K, BURCHHARDT M, ALBRECHT, M, MICHEL U. Soluble intercellular adhesion molecule-1 (s-ICAM-1) is produced by cerebroendothelial cells and blocks cell adhesion. Can J Neurol Sci 1993a: 20: 131.
8. SETH R, RAYMOND FD, MAKGOBA MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991: 338: 83-4.
9. RIECKMANN P, MICHEL U, ALBRECHT M, BRUCK W, WOCKEL L, FELGENHAUER K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 1995: 60: 9-15.
10. JANDER S, HEIDENREICH F, STOLL G. Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology 1993: 43: 1809-13.
11. RIECKMANN P, NÜNKE K, BURCHHARDT M et al. Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J Neuroimmunol 1993b: 47: 133-40.
12. SHARIEF MK, NOORI MA, CIARDI M, CIRELLI A, THOMPSON EJ. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage. J Neuroimmunol 1993: 43 15-22.
13. DROOGAN AG, MCMILLAN SA, DOUGLAS JP, HAWKINS SA. Serum and cerebrospinal levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of cell adhesion molecule-1. J Neuroimmunol 1996: 64: 185-91.
14. RIECKMANN P, MARTIN S, WEICHSELBRAUN I et al. Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: c-ICAM-1 is an indicator for relapse. Neurology 1994: 44: 2367-72.
15. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
16. KATZ, D, TAUBENBERGER JK, CANNELLA B et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993: 34: 661-9.
17. MITCHELL JR, KARLIK SJ, LEE DH et al. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Med Phys 1996: 23: 85-97.
18. FILLIPPI M, HORSFIELD MA, BRESSI S et al. Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. Brain 1995: 118: 1593-1600.
19. TSUKADA N, MATSUDA M, MIYAGI K, YANAGISAWA N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology 1993: 43: 2679-82.
20. MAKGOBA MW, SANDERS ME, GINTHER-LUCE et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T, and myeloid cells. Nature 1988: 331: 86-8.
21. CROSS AH. Immune cell traffic control and the central nervous system. Semin Neurosci 1992: 4: 213-19.
22. CANNELLA B, CROSS AH, RAINE CS. Adhesion-related molecules in the central nervous system: Upregulation correlated with inflammatory cell influx during relapsing experimental autoimmune encephalitis. Lab Invest 1991: 65: 23-31.
23. ARCHELOS JJ, MÄURER M, JUNG S, TOYKA KV, HÄRTUNG HP. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 1993: 34: 145-54.
24. ENGELHARDT B, CONLEY FK, KILSHAW PJ, BUTCHER EC. Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MadCAM-1. Int Immunol 1995: 7: 481-91.
25. CANNELLA B, RAINE CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995: 37: 424-35.
26. BRUCK W, PORADA P, POSER S et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995: 38: 788-96.
27. LI H, NEWCOMBE J, GROOME NP, CUZNER ML. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol 1993: 19: 214-23.
28. TOURTELLOTTE WW, MA BJ. Multiple Sclerosis: The blood-brain barrier and the measurement of de novo central nervous system IgG synthesis. Neurology 1978: 28: 76-83.
29. GAY D, ESIRI M. Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study. Brain 1991: 114 557-72.
30. PIGOTT R, DILON LP, HEMINGWAY IK, GEARING AJH. Soluble forms of E-Selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine activated endothelial cells. Biophys Res Commun 1992: 187: 584-9.
31. STEFFEN BJ, BREIER G, BUTCHER EC, SCHULZ M, ENGELHARDT B, ICAM-1, VCAM-1 and MAdAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol 1996: 148: 1819-38.
32. HANSEN AB, LILLEVANG ST, ANDERSEN CB. Stimulation of intercellular adhesion molecule-1 (ICAM-1) antigen expression and shedding by interferon-gamma and phorbol ester in human renal carcinoma cell cultures: relation to peripheral blood mononuclear cell adhesion. Urol Res 1994: 22: 85-91.
33. ROTHLEIN R, MAINOLFI EA, CZAJKOWSKI M, MARLIN SD. A form of circulating ICAM-1 in human serum. J Immunol 1991: 147: 3788-93.